Nina V. Zarochentseva
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Nina V. Zarochentseva has a total of 109 co-authors. Here are the top co-authors by number of shared publications:
- Igor I. Baranov
Federal State Budgetary Institution «Academician V.I. Kulakov National Medical Research Center of Obstetrics, Gynecology, and Perinatology» of the Russian Ministry of Health
5 shared publications - L.K. Dzhidzhikhiya
ГБУЗ МО «Московский областной научно-исследовательский институт акушерства и гинекологии имени академика В.И. Краснопольского
5 shared publications - Inna V. Kardava
Moscow Regional Research Institute of Obstetrics and Gynecology
4 shared publications - Olga V. Trishchenkova
Moscow Regional Research Institute of Obstetrics and Gynecology
4 shared publications - Aleksandr R. Fattakhov
Moscow Regional Research Institute of Obstetrics and Gynecology n.a. Academician V.I. Krasnopolsky
2 shared publications - Irina V. Barinova
Moscow Regional Research Institute of Obstetrics and Gynecology named after Academician V.I. Krasnopolsky
2 shared publications
Latest Publications
- Open Access
- 18 January 2026
- Published by Endocrinology Research Centre in Problems of Endocrinology
- Vol. 71 (6) , 40-49
Optimal serum 25(OH)D levels in relation to musculoskeletal, metabolic, neurological, autoimmune and infectious diseases
This article presents an overview of current research on determining target blood levels of vitamin D. It examines the biochemical and metabolic properties of vitamin D, as well as the challenges of standardizing 25(OH)D measurements and the variability of threshold values across populations. It discusses ambiguities in scientific data and the need to consider individual factors when interpreting vitamin D levels. This review is unique in its comprehensive approach to analyzing the effects of vitamin D not only on bone health but also on immune and metabolic functions, which broadens ever evolving understanding of the clinical significance of vitamin D. This work emphasizes the importance of personalized recommendations for vitamin D dosing and prescription based on current clinical data and scientific standards. Performed analysis highlights the need for personalized vitamin D supplementation to reach and maintain blood levels between 30 and 60 ng/mL, noting that higher levels might be necessary for people with genetic or acquired resistance. These insights substantiate the development of evidence-based, personalized clinical strategies for the prevention and treatment of vitamin D deficiency-related disorders. The synthesized data offer significant implications for advancing research and clinical practice in endocrinology, obstetrics, dermatology, neurology and immunology.
- 18 January 2026
- Published by Endocrinology Research Centre in Problems of Endocrinology
- Vol. 71 (6) , 40-49
Open AccessOptimal serum 25(OH)D levels in relation to musculoskeletal, metabolic, neurological, autoimmune and infectious diseases
This article presents an overview of current research on determining target blood levels of vitamin D. It examines the biochemical and metabolic properties of vitamin D, as well as the challenges of standardizing 25(OH)D measurements and the variability of threshold values across populations. It discusses ambiguities in scientific data and the need to consider individual factors when interpreting vitamin D levels. This review is unique in its comprehensive approach to analyzing the effects of vitamin D not only on bone health but also on immune and metabolic functions, which broadens ever evolving understanding of the clinical significance of vitamin D. This work emphasizes the importance of personalized recommendations for vitamin D dosing and prescription based on current clinical data and scientific standards. Performed analysis highlights the need for personalized vitamin D supplementation to reach and maintain blood levels between 30 and 60 ng/mL, noting that higher levels might be necessary for people with genetic or acquired resistance. These insights substantiate the development of evidence-based, personalized clinical strategies for the prevention and treatment of vitamin D deficiency-related disorders. The synthesized data offer significant implications for advancing research and clinical practice in endocrinology, obstetrics, dermatology, neurology and immunology.
- 30 December 2025
- Published by OOO "Opponent" in Медицинский оппонент
- Vol. 32 (4(32)) , 23-27
Экономика скрининга рака шейки матки. Вчера, сегодня, завтра. Часть 2
Рассматриваются проблемы, касающиеся изучения рака шейки матки, совершенствования скрининговых программ профилактического характера, разработки высокотехнологичных методов диагностики данной патологии. Приводится экономическая целесообразность использования метода жидкостной цитологии для скрининга РШМ. Экономические преимущества перехода на ВПЧ-тестирование. Представлен оптико-электронный метод TruScreen (TS) и его влияние на экономику скрининга.
- 30 December 2025
- Published by OOO "Opponent" in Медицинский оппонент
- Vol. 32 (4(32)) , 23-27
Экономика скрининга рака шейки матки. Вчера, сегодня, завтра. Часть 2
Рассматриваются проблемы, касающиеся изучения рака шейки матки, совершенствования скрининговых программ профилактического характера, разработки высокотехнологичных методов диагностики данной патологии. Приводится экономическая целесообразность использования метода жидкостной цитологии для скрининга РШМ. Экономические преимущества перехода на ВПЧ-тестирование. Представлен оптико-электронный метод TruScreen (TS) и его влияние на экономику скрининга.
- 30 September 2025
- Published by OOO "Opponent" in Медицинский оппонент
- Vol. 31 (3(31)) , 47-51
Экономика скрининга рака шейки матки. Вчера, сегодня, завтра. Часть 1
Рассматриваются проблемы, касающиеся изучения рака шейки матки, совершенствования скрининговых программ профилактического характера, разработки высокотехнологичных методов диагностики данной патологии. Приводится экономическая целесообразность использования метода жидкостной цитологии для скрининга РШМ. Экономические преимущества перехода на ВПЧ-тестирование. Представлен оптико-электронный метод TruScreen (TS) и его влияние на экономику скрининга.
- 30 September 2025
- Published by OOO "Opponent" in Медицинский оппонент
- Vol. 31 (3(31)) , 47-51
Экономика скрининга рака шейки матки. Вчера, сегодня, завтра. Часть 1
Рассматриваются проблемы, касающиеся изучения рака шейки матки, совершенствования скрининговых программ профилактического характера, разработки высокотехнологичных методов диагностики данной патологии. Приводится экономическая целесообразность использования метода жидкостной цитологии для скрининга РШМ. Экономические преимущества перехода на ВПЧ-тестирование. Представлен оптико-электронный метод TruScreen (TS) и его влияние на экономику скрининга.
- 17 August 2025
- Published by ECO-Vector LLC in V.F.Snegirev Archives of Obstetrics and Gynecology
- Vol. 12 (3) , 335-342
Efficacy of contour-loop excision and conization of the cervix in high-grade squamous intraepithelial lesions
Background: At present, despite numerous excisional methods for the treatment of High-Grade Squamous Intraepithelial Lesion (HSIL), the rates of residual lesions and recurrences remain rather high, ranging from 30% to 50% regardless of the method chosen. Notably, up to 30% of women remain infected with human papillomavirus after surgical treatment. Therefore, the choice of the optimal excision technique for HSIL is still relevant, as it should reduce the incidence of residual lesions, disease recurrence, and human papillomavirus persistence. Aim: The work aimed to evaluate the efficacy of contour-loop excision (C-LETZ) and classical cervical conization in HSIL. Methods: In 2021–2023, at the Krasnopolsky Moscow Regional Research Institute of Obstetrics and Gynecology, 66 patients with histologically confirmed HSIL were examined, treated, and followed up; classical cervical conization (group 1, n = 32) and contour-loop excision of the cervix using a wave-shaped C-LETZ cone (group 2, n = 34) were performed. Results: Positive endocervical resection margins were observed more frequently after classical cervical conization compared with C-LETZ (р 0.001). Conization more often revealed endocervical crypt involvement at the apex of the excised cone (р = 0.03), as well as the presence of HSIL in endocervical curettage (р = 0.01). In group 1, 8% of women had intraepithelial lesions confined to the endocervical curettage with no involvement in the resected specimens, compared with 0% in group 2. Residual lesions in group 1 were detected in 6% (2/32) within one year of follow-up and in 12% (4/32) between one and two years. Disease recurrence after two years of follow-up was diagnosed in 18% of women (6/32). In group 2, residual lesions were identified in 3% (1/34) within one year and in 6% (2/34) between one and two years. Recurrence after two years was three times less frequent compared with group 1—in 6% of women (2/34); p = 0.01. Conclusion: Due to the wave-shaped structure of the C-LETZ loop, excision allows deeper capture of the endocervix, thereby increasing the volume of resected cervical canal tissue. This contributes to a twofold reduction in positive endocervical margins and human papillomavirus persistence, and a 1.5-fold reduction in residual crypt lesions compared with classical conization. Thus, deeper removal of endocervical tissue with C-LETZ reduces the risk of human papillomavirus persistence, residual lesions, and disease recurrence.
- 17 August 2025
- Published by ECO-Vector LLC in V.F.Snegirev Archives of Obstetrics and Gynecology
- Vol. 12 (3) , 335-342
Efficacy of contour-loop excision and conization of the cervix in high-grade squamous intraepithelial lesions
Background: At present, despite numerous excisional methods for the treatment of High-Grade Squamous Intraepithelial Lesion (HSIL), the rates of residual lesions and recurrences remain rather high, ranging from 30% to 50% regardless of the method chosen. Notably, up to 30% of women remain infected with human papillomavirus after surgical treatment. Therefore, the choice of the optimal excision technique for HSIL is still relevant, as it should reduce the incidence of residual lesions, disease recurrence, and human papillomavirus persistence. Aim: The work aimed to evaluate the efficacy of contour-loop excision (C-LETZ) and classical cervical conization in HSIL. Methods: In 2021–2023, at the Krasnopolsky Moscow Regional Research Institute of Obstetrics and Gynecology, 66 patients with histologically confirmed HSIL were examined, treated, and followed up; classical cervical conization (group 1, n = 32) and contour-loop excision of the cervix using a wave-shaped C-LETZ cone (group 2, n = 34) were performed. Results: Positive endocervical resection margins were observed more frequently after classical cervical conization compared with C-LETZ (р 0.001). Conization more often revealed endocervical crypt involvement at the apex of the excised cone (р = 0.03), as well as the presence of HSIL in endocervical curettage (р = 0.01). In group 1, 8% of women had intraepithelial lesions confined to the endocervical curettage with no involvement in the resected specimens, compared with 0% in group 2. Residual lesions in group 1 were detected in 6% (2/32) within one year of follow-up and in 12% (4/32) between one and two years. Disease recurrence after two years of follow-up was diagnosed in 18% of women (6/32). In group 2, residual lesions were identified in 3% (1/34) within one year and in 6% (2/34) between one and two years. Recurrence after two years was three times less frequent compared with group 1—in 6% of women (2/34); p = 0.01. Conclusion: Due to the wave-shaped structure of the C-LETZ loop, excision allows deeper capture of the endocervix, thereby increasing the volume of resected cervical canal tissue. This contributes to a twofold reduction in positive endocervical margins and human papillomavirus persistence, and a 1.5-fold reduction in residual crypt lesions compared with classical conization. Thus, deeper removal of endocervical tissue with C-LETZ reduces the risk of human papillomavirus persistence, residual lesions, and disease recurrence.
- 17 December 2024
- Published by Media Sphere Publishing Group in Russian Journal of Archive of Pathology
- Vol. 86 (6) , 43-48
Clinical morphology of cervical conization variants for high-grade squamous intraepithelial lesions
Surgical options for organ-preserving operations on the cervix (conization and contour-loop excision (C-LETZ)) regarding squamous intraepithelial lesions, morphological features of the cervix after surgery are determined, which are significant for HPV persistence and reproductive function. Objective. To evaluate the results of a lifetime pathoanatomic examination of the surgical material of cervical conization with diathermy loops of various shapes and sizes — a triangular loop and a wavy C-LETZ loop. Material and methods. The study included 49 patients with a clinical diagnosis of high-severity squamous intraepithelial lesion (HSIL), established by the results of a cytological smear examination or a previous histological examination of a cervical biopsy at the Moscow Regional Research Institute of Obstetrics and Gynecology named after Academician V.I. Krasnopolsky from 2016 to 2023. Histological examination of resected cervical cones (n=32) and wavy C-LETZ cones (n=17) was performed. Results. At a cone height of less than 1.5 cm, both edges of the resection enter the section. With a higher cone height — 1.5—2cm — the endocervical edge of the resection can be examined by cutting and labeling it in a separate cassette. Undulating C-LETZ conization ensures excision of the crypts of the endocervix to a depth of 0.5 cm not only throughout, but also in the endocervical edge of the excision. Conclusion. The analysis of the results of a lifetime pathoanatomic examination of the surgical material of conization with a triangular loop and a wavy C-LETZ loop showed the advantages and disadvantages of each of the studied variants of organ-preserving surgery. The advantage of wavy C-LETZ conization is the deep excision of the crypts of the endocervix throughout the cone, including the endocervical edge of conization.
- 17 December 2024
- Published by Media Sphere Publishing Group in Russian Journal of Archive of Pathology
- Vol. 86 (6) , 43-48
Clinical morphology of cervical conization variants for high-grade squamous intraepithelial lesions
Surgical options for organ-preserving operations on the cervix (conization and contour-loop excision (C-LETZ)) regarding squamous intraepithelial lesions, morphological features of the cervix after surgery are determined, which are significant for HPV persistence and reproductive function. Objective. To evaluate the results of a lifetime pathoanatomic examination of the surgical material of cervical conization with diathermy loops of various shapes and sizes — a triangular loop and a wavy C-LETZ loop. Material and methods. The study included 49 patients with a clinical diagnosis of high-severity squamous intraepithelial lesion (HSIL), established by the results of a cytological smear examination or a previous histological examination of a cervical biopsy at the Moscow Regional Research Institute of Obstetrics and Gynecology named after Academician V.I. Krasnopolsky from 2016 to 2023. Histological examination of resected cervical cones (n=32) and wavy C-LETZ cones (n=17) was performed. Results. At a cone height of less than 1.5 cm, both edges of the resection enter the section. With a higher cone height — 1.5—2cm — the endocervical edge of the resection can be examined by cutting and labeling it in a separate cassette. Undulating C-LETZ conization ensures excision of the crypts of the endocervix to a depth of 0.5 cm not only throughout, but also in the endocervical edge of the excision. Conclusion. The analysis of the results of a lifetime pathoanatomic examination of the surgical material of conization with a triangular loop and a wavy C-LETZ loop showed the advantages and disadvantages of each of the studied variants of organ-preserving surgery. The advantage of wavy C-LETZ conization is the deep excision of the crypts of the endocervix throughout the cone, including the endocervical edge of conization.
- 11 June 2024
- Published by Paediatrician Publishers LLC in Annals of the Russian academy of medical sciences
- Vol. 79 (2) , 158-167
Retrospective Cross-Sectional Epidemiological Study of Human Papillomavirus-Associated Precancers and Anogenital Warts in Patients Attending Specialized Clinics in Russian Federation
Background. In Russia, there are no country level registries on HPV-associated pre-cancers (cervical intraepithelial neoplasia, CIN; vulvar intraepithelial neoplasia, VIN; vaginal intraepithelial neoplasia, VaIN; anal intraepithelial neoplasia, AIN; penile intraepithelial neoplasia PIN) and anogenital warts (AWs) and no national-level cervical cancer screening program. Aims — the aim of this study was to assess the proportion of patients with CIN, VIN, VaIN, AIN, PIN and AWs diagnosis in the clinical settings in Russia. Methods. This study was a non-interventional retrospective multi-center chart-review study in 28 investigational sites representing 21 Federal subjects of 6 Federal Districts of Russia. Medical charts of adult men and women visited gynecology, sexual health, dermatovenerology or urology services between 1 Jan 2000 — 31 Dec 2019 were reviewed. Data were abstracted, using a standardized approach, on patient demographic characteristics, presence or absence of pre-cancers and AWs diagnoses, method of diagnosing pre-cancer and HPV infection, and grade of neoplasia. Results. A total of 11 520 patients (1732 male and 9788 female) were included in the analysis. The overall proportion of patients with HPV-associated precancers and AWs was 10.8%. By service type, cases of HPV-associated conditions were revealed most often in dermatological departments (14.5%) and gynecological hospitals (13.8%). CIN detection rate in Russian clinical settings increased over the 20-years from 3.2 to 11.1% and was higher in gynecological in-patient departments compared to out-patient departments (12.5 and 5.2% respectively). The number of non-cervical precancers (VIN, VaIN, AIN, PIN) cases were very low (the detection rate was less than 1%). The frequency of HPV type 16 and 18 detection increased from 0.6 to 4.8%, and from 0.2 to 1.9%, respectively, for the 20-years period. Conclusions. Our study suggested high level of HPV-related pre-cancer and AW disease burden as well as presence of high-risk HPV types. Preventive strategy through effective national HPV immunization program would be beneficial to reduce HPV-related disease burden in Russia.
- 11 June 2024
- Published by Paediatrician Publishers LLC in Annals of the Russian academy of medical sciences
- Vol. 79 (2) , 158-167
Retrospective Cross-Sectional Epidemiological Study of Human Papillomavirus-Associated Precancers and Anogenital Warts in Patients Attending Specialized Clinics in Russian Federation
Background. In Russia, there are no country level registries on HPV-associated pre-cancers (cervical intraepithelial neoplasia, CIN; vulvar intraepithelial neoplasia, VIN; vaginal intraepithelial neoplasia, VaIN; anal intraepithelial neoplasia, AIN; penile intraepithelial neoplasia PIN) and anogenital warts (AWs) and no national-level cervical cancer screening program. Aims — the aim of this study was to assess the proportion of patients with CIN, VIN, VaIN, AIN, PIN and AWs diagnosis in the clinical settings in Russia. Methods. This study was a non-interventional retrospective multi-center chart-review study in 28 investigational sites representing 21 Federal subjects of 6 Federal Districts of Russia. Medical charts of adult men and women visited gynecology, sexual health, dermatovenerology or urology services between 1 Jan 2000 — 31 Dec 2019 were reviewed. Data were abstracted, using a standardized approach, on patient demographic characteristics, presence or absence of pre-cancers and AWs diagnoses, method of diagnosing pre-cancer and HPV infection, and grade of neoplasia. Results. A total of 11 520 patients (1732 male and 9788 female) were included in the analysis. The overall proportion of patients with HPV-associated precancers and AWs was 10.8%. By service type, cases of HPV-associated conditions were revealed most often in dermatological departments (14.5%) and gynecological hospitals (13.8%). CIN detection rate in Russian clinical settings increased over the 20-years from 3.2 to 11.1% and was higher in gynecological in-patient departments compared to out-patient departments (12.5 and 5.2% respectively). The number of non-cervical precancers (VIN, VaIN, AIN, PIN) cases were very low (the detection rate was less than 1%). The frequency of HPV type 16 and 18 detection increased from 0.6 to 4.8%, and from 0.2 to 1.9%, respectively, for the 20-years period. Conclusions. Our study suggested high level of HPV-related pre-cancer and AW disease burden as well as presence of high-risk HPV types. Preventive strategy through effective national HPV immunization program would be beneficial to reduce HPV-related disease burden in Russia.
- 30 January 2024
- Published by Media Sphere Publishing Group in Russian Bulletin of Obstetrician-Gynecologist
- Vol. 24 (1)
Hyperprolactinaemia and reproductive health of women
Objective. Optimisation of pregravidal preparation of patients with various forms of hyperprolactinemia to increase reproductive potential. Material and methods. Prospective examination and treatment of 58 patients with different types of hyperprolactinemia were carried out. Depending on the type of hyperprolactinemia all patients were divided into 4 groups: patients with functional hyperprolactinemia, microadenoma and macroadenoma of pituitary gland and macroprolactinemia’s phenomenon. The examination of patients included a standard range of laboratory and instrumental investigations. Results. The peculiarities of menstrual cycle and reproductive function disorders, frequency of development of concomitant endocrine and somatic diseases in different forms of hyperprolactinemia were studied. As a result of complex pregravidal preparation of patients with hyperprolactinemia pregnancy occurred in 25 (86%) out of 29 women who planned it. At the same time, 11 (44%) patients became pregnant against the background of cabergoline treatment and 3—6 months after its cancellation, and 14 (56%) patients additionally underwent ovulation stimulation cycles. Conclusion. To restore the regulation of menstrual cycle and reproductive function in patients with hyperprolactinemia of different genesis it is reasonable to use dopamine agonists, gestagens, as well as estrogens and inducers of ovulation.
- 30 January 2024
- Published by Media Sphere Publishing Group in Russian Bulletin of Obstetrician-Gynecologist
- Vol. 24 (1)
Hyperprolactinaemia and reproductive health of women
Objective. Optimisation of pregravidal preparation of patients with various forms of hyperprolactinemia to increase reproductive potential. Material and methods. Prospective examination and treatment of 58 patients with different types of hyperprolactinemia were carried out. Depending on the type of hyperprolactinemia all patients were divided into 4 groups: patients with functional hyperprolactinemia, microadenoma and macroadenoma of pituitary gland and macroprolactinemia’s phenomenon. The examination of patients included a standard range of laboratory and instrumental investigations. Results. The peculiarities of menstrual cycle and reproductive function disorders, frequency of development of concomitant endocrine and somatic diseases in different forms of hyperprolactinemia were studied. As a result of complex pregravidal preparation of patients with hyperprolactinemia pregnancy occurred in 25 (86%) out of 29 women who planned it. At the same time, 11 (44%) patients became pregnant against the background of cabergoline treatment and 3—6 months after its cancellation, and 14 (56%) patients additionally underwent ovulation stimulation cycles. Conclusion. To restore the regulation of menstrual cycle and reproductive function in patients with hyperprolactinemia of different genesis it is reasonable to use dopamine agonists, gestagens, as well as estrogens and inducers of ovulation.
- 23 April 2023
- Published by Media Sphere Publishing Group in Russian Bulletin of Obstetrician-Gynecologist
- Vol. 23 (6)
Methods of prevention of vaginal intraepithelial neoplasia in HPV-positive patients under radical surgery
In the review of scientific literature the methods of prophylaxis of vaginal intraepithelial neoplasia in HPV-positive patients, including those who underwent hysterectomy for diseases of the uterine body and cervix, are highlighted. In most cases, vaginal intraepithelial neoplasia developed in the upper third of the vagina, and the middle and lower thirds were affected in less than 10% of cases. Intraepithelial vaginal neoplasia provoked by insufficient excision of the vaginal wall during hysterectomy was detected in 39.5% of patients. Despite radical volumes of operations in surgical treatment of diseases of the body and cervix (hysterectomy), vaginal cancer was observed especially often in HPV-positive patients. Vaginal resection in HPV-positive patients during hysterectomy may be a method of vaginal cancer prevention.
- 23 April 2023
- Published by Media Sphere Publishing Group in Russian Bulletin of Obstetrician-Gynecologist
- Vol. 23 (6)
Methods of prevention of vaginal intraepithelial neoplasia in HPV-positive patients under radical surgery
In the review of scientific literature the methods of prophylaxis of vaginal intraepithelial neoplasia in HPV-positive patients, including those who underwent hysterectomy for diseases of the uterine body and cervix, are highlighted. In most cases, vaginal intraepithelial neoplasia developed in the upper third of the vagina, and the middle and lower thirds were affected in less than 10% of cases. Intraepithelial vaginal neoplasia provoked by insufficient excision of the vaginal wall during hysterectomy was detected in 39.5% of patients. Despite radical volumes of operations in surgical treatment of diseases of the body and cervix (hysterectomy), vaginal cancer was observed especially often in HPV-positive patients. Vaginal resection in HPV-positive patients during hysterectomy may be a method of vaginal cancer prevention.
- 23 April 2023
- Published by Media Sphere Publishing Group in Russian Bulletin of Obstetrician-Gynecologist
- Vol. 23 (5)
Predictors of recurrence of cervical intraepithelial neoplasia of high severity after treatment with excisional methods
ЦЕЛЬ ИССЛЕДОВАНИЯ Определение факторов, влияющих на развитие рецидивов интраэпителиальных неоплазий шейки матки высокой степени тяжести (HSIL/CIN2+) после лечения эксцизионными методами. МАТЕРИАЛ И МЕТОДЫ Проведено ретроспективное обследование 105 пациенток репродуктивного возраста с цервикальной интраэпителиальной неоплазией (CIN) высокой степени тяжести (HSIL), которым выполнялось хирургическое лечение в объеме эксцизии или конизации шейки матки с последующим наблюдением. Проводились общеклинические обследования, цитологическое исследование мазков с экзо-, эндоцервикса (окрашивание гематоксилином и эозином), тестирование на вирус папилломы человека (ВПЧ) с генотипированием (14 типов), расширенная кольпоскопия и биопсия шейки матки, а также оценка наличия или отсутствия вакцинации против ВПЧ высокого карциногенного риска (ВКР) до развития рецидива. РЕЗУЛЬТАТЫ Общий уровень инфицирования до хирургического лечения составил 88,6% (93 из 105). Были выделены 9 ключевых факторов, влияющих на развитие рецидива цервикальных интраэпителиальных неоплазий. Персистенция ВПЧ-инфекции после проведенной манипуляции наблюдалась у 39 (37,1%) пациенток, среди них у 22 (56,4%) развился рецидив. Наличие ВПЧ ВКР в вирусной нагрузке ≥6,3 Lg (копии/образец) до лечения статистически значимо увеличивало риск развития рецидивных форм. Данный показатель был диагностирован у 40 (38,1%) женщин и привел к неудачному лечению в 90% (36 из 40) наблюдений. Чаще выявлялся ВПЧ 16-го типа (n=67; 63,8%), который в 49,3% (33 из 67) наблюдений вызывал рецидивы. При положительном крае резекции (в случае сохранения дисплазии в краях резекции) среди 21 (20%) пациентки у 10 (47,6%) наблюдалось повторное развитие CIN. Наличие поражения в соскобе из цервикального канала и поражения крипт также было сопряжено с увеличением риска выявления рецидивных форм после лечения в 40,7% (11 из 27) и 28,6% (8 из 28) наблюдений соотвественно. Важными факторами риска являются возраст пациентки старше 37 лет (n=22; 52,4%), начало половой жизни ранее 20 лет (n=37; 40,2%), отсутствие вакцинации против ВПЧ до развития рецидива (n=40; 70,2%), а также перенесенная новая коронавирусная инфекция COVID-19 (n=8; 88,9%). Повторное инфицирование после эксцизионного лечения наблюдалось у 14 (13,3%) пациенток, среди которых у 6 развился рецидив CIN. ЗАКЛЮЧЕНИЕ Своевременное выявление и оценка предикторов возможного неудачного лечения HSIL/CIN2+ являются значимыми и актуальными в прогнозировании развития рецидивных форм после лечения эксцизионными методами.
- 23 April 2023
- Published by Media Sphere Publishing Group in Russian Bulletin of Obstetrician-Gynecologist
- Vol. 23 (5)
Predictors of recurrence of cervical intraepithelial neoplasia of high severity after treatment with excisional methods
ЦЕЛЬ ИССЛЕДОВАНИЯ Определение факторов, влияющих на развитие рецидивов интраэпителиальных неоплазий шейки матки высокой степени тяжести (HSIL/CIN2+) после лечения эксцизионными методами. МАТЕРИАЛ И МЕТОДЫ Проведено ретроспективное обследование 105 пациенток репродуктивного возраста с цервикальной интраэпителиальной неоплазией (CIN) высокой степени тяжести (HSIL), которым выполнялось хирургическое лечение в объеме эксцизии или конизации шейки матки с последующим наблюдением. Проводились общеклинические обследования, цитологическое исследование мазков с экзо-, эндоцервикса (окрашивание гематоксилином и эозином), тестирование на вирус папилломы человека (ВПЧ) с генотипированием (14 типов), расширенная кольпоскопия и биопсия шейки матки, а также оценка наличия или отсутствия вакцинации против ВПЧ высокого карциногенного риска (ВКР) до развития рецидива. РЕЗУЛЬТАТЫ Общий уровень инфицирования до хирургического лечения составил 88,6% (93 из 105). Были выделены 9 ключевых факторов, влияющих на развитие рецидива цервикальных интраэпителиальных неоплазий. Персистенция ВПЧ-инфекции после проведенной манипуляции наблюдалась у 39 (37,1%) пациенток, среди них у 22 (56,4%) развился рецидив. Наличие ВПЧ ВКР в вирусной нагрузке ≥6,3 Lg (копии/образец) до лечения статистически значимо увеличивало риск развития рецидивных форм. Данный показатель был диагностирован у 40 (38,1%) женщин и привел к неудачному лечению в 90% (36 из 40) наблюдений. Чаще выявлялся ВПЧ 16-го типа (n=67; 63,8%), который в 49,3% (33 из 67) наблюдений вызывал рецидивы. При положительном крае резекции (в случае сохранения дисплазии в краях резекции) среди 21 (20%) пациентки у 10 (47,6%) наблюдалось повторное развитие CIN. Наличие поражения в соскобе из цервикального канала и поражения крипт также было сопряжено с увеличением риска выявления рецидивных форм после лечения в 40,7% (11 из 27) и 28,6% (8 из 28) наблюдений соотвественно. Важными факторами риска являются возраст пациентки старше 37 лет (n=22; 52,4%), начало половой жизни ранее 20 лет (n=37; 40,2%), отсутствие вакцинации против ВПЧ до развития рецидива (n=40; 70,2%), а также перенесенная новая коронавирусная инфекция COVID-19 (n=8; 88,9%). Повторное инфицирование после эксцизионного лечения наблюдалось у 14 (13,3%) пациенток, среди которых у 6 развился рецидив CIN. ЗАКЛЮЧЕНИЕ Своевременное выявление и оценка предикторов возможного неудачного лечения HSIL/CIN2+ являются значимыми и актуальными в прогнозировании развития рецидивных форм после лечения эксцизионными методами.
- 14 April 2023
- Published by Media Sphere Publishing Group in Russian Bulletin of Obstetrician-Gynecologist
- Vol. 23 (2)
The significance of high-risk carcinogenic human papillomavirus type identification and vaccination after surgical treatment in the development of cervical intraepithelial neoplasia recurrence
ЦЕЛЬ ИССЛЕДОВАНИЯ Определить значение генотипирования вируса папилломы человека высокого канцерогенного риска и вакцинации после хирургического лечения в развитии рецидивов интраэпителиальных неоплазий шейки матки. МАТЕРИАЛ И МЕТОДЫ Проведено ретроспективное исследование 105 женщин репродуктивного возраста с цервикальными интраэпителиальными неоплазиями высокой степени, которым проводилось эксцизионное лечение с последующим наблюдением. Проводились клинический осмотр, контроль цитологического исследования мазков с экзо-, эндоцервикса (окрашивание гематоксилином и эозином), ВПЧ-тестирование с генотипированием (14 типов) методом полимеразной цепной реакции в режиме реального времени (AmpliSens), расширенная кольпоскопия через 3, 6, 12 и 24 мес после лечения. РЕЗУЛЬТАТЫ При проведении ВПЧ-типирования до хирургического лечения общий уровень инфицирования составил 88,6% (93/105). ВПЧ 16-го типа (63,8%), 18-го типа (14,3%) и 33-го типа (16,2%) были тремя наиболее распространенными типами. Всем пациенткам с HSIL было проведено хирургическое лечение в объеме эксцизии (n=32, 30,5%) и конизации (n=73, 69,5%) шейки матки. ВПЧ-позитивными через 3 мес остались 41,9% (39 из 93 пациенток). ВПЧ 16-го типа в 49,3% наблюдений вызывал рецидивы (33 из 67), ВПЧ 56-го типа — у 4 пациенток из 6, за ними следовали ВПЧ 18-го типа — у 5 из 15, ВПЧ 33-го типа — у 9 из 17 и ВПЧ 31-го типа — у 4 из 8. Повторное инфицирование после эксцизионного лечения установлено в 13,1% наблюдений. Суммарно у всех наблюдаемых рецидив возник у 49 (46,7%) из 105 пациенток. Через 2 года наблюдения среди 48 вакцинированных рецидив развился у 6 (12,5%) женщин. У невакцинированных пациенток рецидив в течение 2 лет был выявлен в 22,8% наблюдений (13 из 57). При дальнейшем наблюдении до 5 и 7 лет у вакцинированных пациенток рецидив возник еще в 4,2% (2 из 48) и в 2,1% наблюдений (1 из 48) соответственно. В группе невакцинированных пациенток по истечении 5 лет рецидивные формы возникли у 31,6% (18 из 57), а по истечении 7 лет — у 15,8% (9 из 57). ЗАКЛЮЧЕНИЕ Пациентки после лечения HSIL должны наблюдаться длительно. Повышен риск развития рецидива цервикальной интраэпителиальной неоплазии 16, 18, 31, 33 и 56-го генотипов ВПЧ. Проведение ВПЧ-типирования после эксцизионного лечения HSIL является важным анализом в прогнозировании риска развития рецидива.
- 14 April 2023
- Published by Media Sphere Publishing Group in Russian Bulletin of Obstetrician-Gynecologist
- Vol. 23 (2)
The significance of high-risk carcinogenic human papillomavirus type identification and vaccination after surgical treatment in the development of cervical intraepithelial neoplasia recurrence
ЦЕЛЬ ИССЛЕДОВАНИЯ Определить значение генотипирования вируса папилломы человека высокого канцерогенного риска и вакцинации после хирургического лечения в развитии рецидивов интраэпителиальных неоплазий шейки матки. МАТЕРИАЛ И МЕТОДЫ Проведено ретроспективное исследование 105 женщин репродуктивного возраста с цервикальными интраэпителиальными неоплазиями высокой степени, которым проводилось эксцизионное лечение с последующим наблюдением. Проводились клинический осмотр, контроль цитологического исследования мазков с экзо-, эндоцервикса (окрашивание гематоксилином и эозином), ВПЧ-тестирование с генотипированием (14 типов) методом полимеразной цепной реакции в режиме реального времени (AmpliSens), расширенная кольпоскопия через 3, 6, 12 и 24 мес после лечения. РЕЗУЛЬТАТЫ При проведении ВПЧ-типирования до хирургического лечения общий уровень инфицирования составил 88,6% (93/105). ВПЧ 16-го типа (63,8%), 18-го типа (14,3%) и 33-го типа (16,2%) были тремя наиболее распространенными типами. Всем пациенткам с HSIL было проведено хирургическое лечение в объеме эксцизии (n=32, 30,5%) и конизации (n=73, 69,5%) шейки матки. ВПЧ-позитивными через 3 мес остались 41,9% (39 из 93 пациенток). ВПЧ 16-го типа в 49,3% наблюдений вызывал рецидивы (33 из 67), ВПЧ 56-го типа — у 4 пациенток из 6, за ними следовали ВПЧ 18-го типа — у 5 из 15, ВПЧ 33-го типа — у 9 из 17 и ВПЧ 31-го типа — у 4 из 8. Повторное инфицирование после эксцизионного лечения установлено в 13,1% наблюдений. Суммарно у всех наблюдаемых рецидив возник у 49 (46,7%) из 105 пациенток. Через 2 года наблюдения среди 48 вакцинированных рецидив развился у 6 (12,5%) женщин. У невакцинированных пациенток рецидив в течение 2 лет был выявлен в 22,8% наблюдений (13 из 57). При дальнейшем наблюдении до 5 и 7 лет у вакцинированных пациенток рецидив возник еще в 4,2% (2 из 48) и в 2,1% наблюдений (1 из 48) соответственно. В группе невакцинированных пациенток по истечении 5 лет рецидивные формы возникли у 31,6% (18 из 57), а по истечении 7 лет — у 15,8% (9 из 57). ЗАКЛЮЧЕНИЕ Пациентки после лечения HSIL должны наблюдаться длительно. Повышен риск развития рецидива цервикальной интраэпителиальной неоплазии 16, 18, 31, 33 и 56-го генотипов ВПЧ. Проведение ВПЧ-типирования после эксцизионного лечения HSIL является важным анализом в прогнозировании риска развития рецидива.